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Abstract 
Some biological systems detect the rate of change in a stimulus rather than the stimulus itself 
only. We suggest that the immune system works in this way. According to the discontinuity 
theory of immunity, the immune system responds to sudden changes in antigenic stimulation and 
is rendered tolerant by slow or continuous stimulation. This basic principle, which is supported 
by recent data on immune checkpoints in viral infections, cancers, and allergies, can be seen as a 
unifying framework for diverse immune responses. 
 
 
Key bullet points: 
• Like many other biological systems, the immune system can be seen as a change-
detection system. 
• The immune system detects sudden modifications, but is rendered tolerant to slow 
changes or chronic antigen expression. 
• This view is supported by many recent data and opens up new avenues for research and 
treatment. 
• Further studies of the timing of the immune response, at the interface between 
immunology and biomathematics, are required. 
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The discontinuity theory of immunity in the context of change-detection systems in biology 
Imagine a toad sitting in the close vicinity of a fly. Whilst the fly remains still, the toad does not 
move, but as soon as the fly moves, the toad snaps at it. This natural pattern of behavior, which 
can be observed directly, indicates that the toad detects rapid changes in a visual stimulus, rather 
than the stimulus itself only. Many biological systems behave in a similar fashion, not perceiving 
the stimulus itself only, but detecting the rate of change in the stimulus, a feature related to 
Weber’s law (1, 2). According to this law, which was first proposed in 1905, our visual 
perception of a given stimulus depends not on the absolute level of the stimulus, but on its 
magnitude relative to background levels. It has recently been shown that several cellular 
signaling pathways, including the ERK2 response to EGF and the influence of β-catenin on Wnt 
signaling, involve the detection of changes in a stimulus (1).  
 Here, we argue that change-detection may also be a basic organizing principle underlying 
the workings of the immune system, constituting a pillar of the “discontinuity theory of 
immunity” (3). According to this theory, the immune system detects antigenic variations (Δa) 
over time (Δt): the Δa/Δt derivative. Consequently, the immune system can detect sudden 
changes, leading to the triggering of effector immune responses. Such a concept has been 
pioneered for adaptive immune cells by Grossman and Paul for decades (4, 5). The discontinuity 
theory of immunity applies to both innate and adaptive immunity. Importantly, the immune 
system can also adapt to slow or long-lasting modifications in the host, which it then treats as a 
new reference point. Thus, effector immune responses are induced by sudden antigenic changes, 
whereas chronic exposure to antigens leads to immune tolerance (3). High, but continuous 
antigen concentrations and low levels of variation of antigen concentration (Δa/Δt → 0) would, 
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therefore, be predicted to lead to immune tolerance (Table 1). We explore the effects of 
chronicity, for which large amounts of data have recently been published, in more detail here. 
 
Recent experimental evidence supporting the discontinuity theory of immunity 
The timing of exposure to a given immune stimulus, such as an antigen, plays a major role in the 
triggering of the immune response (4–8), together with other factors, such as the dose and 
molecular structure of the antigen. The discontinuity theory stems from the demonstration that 
chronic exposure to immune stimuli can desensitize both adaptive (9) and innate immune cells 
(10, 11). This theory is supported by an array of recent experimental evidence in three 
pathological contexts: viral infections, cancers, and allergies. In all these contexts, the immune 
effector response declines when the immune system is confronted with the chronic presence of an 
immune stimulus. The tolerogenic mechanisms at work in cases of persistent exposure of the 
immune system to an antigen have been dissected at length by many groups and may be intrinsic 
or extrinsic to the immune cell (Table 1). Intrinsic mechanisms include cell surface receptor 
internalization (e.g., antigen receptors expressed by T and B lymphocytes are internalized upon 
antigen recognition) and the degradation of key downstream signaling elements. Other cell 
intrinsic regulatory circuits include the engagement of co-inhibitory receptors that dampen cell 
activation. These receptors include immune receptor tyrosine-based inhibition motif (ITIM)‐
containing cell surface molecules such as Killer cell Ig-like receptors (KIRs), TIGIT, and CD47, 
and so-called immune checkpoints such as PD-1, CTLA-4, Lag-3, and Tim-3 (12). Although 
these receptors can be expressed in many different immunological situations (e.g., PD-1 is 
expressed on functional follicular T helper cells), they are often induced upon sustained cell 
activation, illustrating a molecular mechanism by which chronic stimulation leads to the 
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desensitization of immune effectors (9). Tolerogenic mechanisms can also be cell-extrinsic, as 
exemplified by the production of immunoregulatory cytokines, such as IL-10 or TGF-β, by 
regulatory T cells induced by persistent antigenic stimulation (13). Exposure to tissue 
autoantigens leads to the activation of self-reactive regulatory T cells. These cells persist in 
tissues and suppress autoimmune responses (14). Continuous T-cell receptor signaling is critical 
for both the development of regulatory T cells in the thymus and for the maintenance and 
function of these cells in the periphery (15). 
 In chronic viral infections, the immune system often deteriorates to “exhaustion” (16), a 
state in which T lymphocytes are first primed and develop effector functions, but then prolonged 
stimulation leads to a gradual loss of function over time (13). In chronic lymphocytic 
choriomeningitis virus infections in mice, cytotoxic lymphocytes adapt to the persistent infection 
via a positive feedback pathway between PD-1 and the transcription factor FoxO1, leading to 
their desensitization (17).  
 This concept has also been clinically validated for tumors, in which chronic exposure to 
tumors also induces exhaustion (18). Immune checkpoints prevent overt activation of the immune 
system and protect normal tissues from collateral damage. Tumor cells often evade immune 
attack, as the ligands for these inhibitory receptors are expressed by the tumor cells themselves or 
by cells in the tumor microenvironment. There has been a recent paradigm shift in cancer 
immunotherapy, with the introduction of treatments based on antibodies called immune 
checkpoint inhibitors, which block the interaction between checkpoints and their ligands. These 
inhibitors make immune cell activation possible, by blocking a dominant inhibitory mechanism. 
Immune checkpoint inhibitors have been shown to be effective and to have manageable safety 
profiles for several types of cancer (19). The demonstration that such treatments can abolish 
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immunological tolerance to the tumor indicates that it is possible to re-introduce discontinuity in 
tumor antigen perception. 
Another confirmation of the induction of immune tolerance by chronic antigen exposure 
has been provided by advances in allergen immunotherapy over the last decade, with some 
degree of desensitization being induced by repeated allergen injections in patients. This method 
has proved effective for allergic rhinitis, allergic asthma, and food allergies (20). 
In many situations, immune tolerance is thus induced by interactions with antigens to 
which the body is chronically exposed, consistent with the discontinuity theory of immunity 
(Table 1). However, no induction of immune tolerance is observed in chronic inflammatory 
disorders. Immunological stimulation is thought to be persistent in these conditions, but this has 
yet to be demonstrated. There may be oscillations in the exposure of the immune system to 
immunological stimuli, preventing the induction of tolerance (3). Further studies are required to 
determine whether chronic inflammatory conditions can develop when the immune system is 
faced with the intermittent presentation of a persistent stimulus.  
The discontinuity theory of immunity can also serve as the basis of innovative therapeutic 
strategies. This theory is consistent with the occurrence of flare-ups in several autoimmune 
disorders, and suggests that these flare-ups may reflect intermittent interactions between immune 
receptors and autoantigens. It also suggests that desensitization strategies might be useful in the 
treatment of autoimmune diseases, to induce tolerance by subjecting the immune system to 
continuous exposure to the autoimmune stimulus. These predictions generate novel, testable 
research hypotheses.  
 
A unifying framework for immunology 
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The discontinuity theory of immunity is based on two founding principles: the important role of 
time in the immune response, and the frequent detection, by the immune system, of modifications 
internal to the host. Indeed, the triggering of an immune response is a complex process based on 
the integration of many different signals, including antigen structure and the context in which 
recognition occurs (21). Several different modes of immune recognition can, thus, be 
distinguished (21, 22): recognition of patterns (either intracellularly or extracellularly, by pattern 
recognition receptors), recognition of the absence of a pattern (“missing self” as with NK cells, 
macrophages or complement), recognition of tissue damage, or recognition of functional 
modifications (as exemplified by the “guard hypothesis” in plants (23)). 
We suggest that all these modes of recognition are instances of the general rule that the 
immune system senses sudden changes in the organism (Figure 1). It is now well-established 
that, in addition to their classical role in the sensing of “nonself” or “danger”, many immune cells 
detect internal disturbances. This is the case for many “innate” immune cells, including NK cells 
and macrophages (3), as well as “adaptive” immune cells (5). More generally, the detection of 
structural modifications to the host seems to have played a major role in the evolution of immune 
systems. Many organisms seem to make use of such an economical system for detecting internal 
change rather than a more costly system based on the detection of structural features of 
pathogens. Several examples of “effector-triggered immunity” have now been described in 
studies of the so-called “guard hypothesis” in plants (23), and in invertebrates (24). Primitive 
chordates also have NK-like systems (detecting missing or modified self) (25), lending support to 
speculations that the immune recognition of major changes in the host has been a driving force in 
the evolution of the immune system, and that the perception of missing or modified self in 
vertebrates is a remnant of this evolutionarily ancient system. Many other recent data tend to the 
same conclusion, including, for example, the demonstrations that an endogenous caspase-11 
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ligand elicits the release of interleukin-1 from living dendritic cells (26), that an innate pathway 
activated by disturbance of the mucus layer exerts an antiviral effect preceding the action of 
interferon (27), and that a guard-like mechanism of pyrin regulation exists in human (28). 
 Immune mechanisms of change-detection are well known, and some were first described 
decades ago. However, the processes underlying the recognition of patterns, an absence of 
pattern, tissue damage, and functional modifications have generally been considered to be 
separate phenomena, with different explanations. The discontinuity theory of immunity 
encompasses all these different modes of recognition in a single explanatory framework, 
according to which immune systems have been selected during evolution for their capacity to 
sense sudden modifications in the body. The question whether mechanisms of immune 
recognition diverged from a common mechanism of change recognition or many mechanisms of 
immune recognition converged on a common strategy of change recognition remains open.   
Herbert Feigl (29) once pointed out that “the aim of scientific explanation throughout the 
ages has been unification, i.e. the comprehending of a maximum of facts and regularities in terms 
of a minimum of theoretical concepts and assumptions.” In a similar vein, the discontinuity 
theory of immunity seeks to provide a single, simple explanation for many different 
immunological phenomena.  
One key lesson to be drawn from the framework suggested here is the need for more 
detailed studies of the time course of the immune response. Along this line, a pivotal element in 
the organization of the immune system resides in its capacity to adapt to slow or long-lasting 
modifications in the host, which it then treats as a new reference point. The duration of the 
stimulation needed for inducing immune responses must be thus compared to the time required 
for the immune system to adapt to the same stimulation. An illustration of the importance of these 
kinetics parameters resides in the killing of MHC class I-negative targets by NK cells raised in a 
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MHC class I-positive environment, and the incapacity of NK cells raised in a MHC class I-
negative environment to kill the same targets. Adoptive transfer experiments indicate that it takes 
several days to a whole population of NK cells to adapt to the chronic loss of MHC Class I in 
their environment, although it takes a few hours for a whole population of NK cells to kill MHC 
Class I-negative cells in vivo (30, 31). Quantitative investigations on the impact of time and 
antigenic dose would be facilitated by much needed collaboration between immunologists and 
biomathematicians, extending beyond traditional disciplinary boundaries (32). 
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Figure legends 
 
Figure 1. The discontinuity theory provides a unifying framework for known immunological 
mechanisms. The mechanisms underlying the recognition of patterns, absence of a pattern, tissue 
damage, and functional modifications have been considered separately, but the discontinuity 
theory explains these mechanisms as instances of the more general rule that immune systems 
have been selected by evolution to respond to sudden modifications within the host. 
  
 13 
Figure 1 
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Table 1  
 
Type of stimulation Graph Examples Immune 
response 
Continuous 
Weak stimulation 
and/or weak 
costimulation 
 
 
 
Anergy 
Tolerogenic 
Chronic stimulation 
 
 
 
- Intrinsic (e.g., 
CTLA-4 or PD-1) 
- Extrinsic (e.g., 
TRegs) 
Discontinuous 
Sudden appearance 
of a pathogen 
 
- Recognition of 
patterns 
- Recognition of the 
absence of a pattern 
- Recognition of 
tissue damage 
- Recognition of 
functional 
modifications 
Effector 
Sudden appearance 
of tumor antigens 
Sudden metabolic 
modification 
 
Table 1. Weak or chronic stimulations lead to a tolerogenic immune response while sudden 
modifications lead to an effector immune response. On the graphs, the blue line represents 
antigen concentration and the red line represents the immune response. 
 
 
 
 
 
 
 
